Mechanistically, we found that IGF2BP1 increases the expression of its newly identified target- SEMA3A by stabilizing its mRNA, thereby upregulating its protein levels in NB cells and eventually in the secreted NB-EVs. Here, IGF2BP1 is linked to neuroblastoma.